Pular para o conteúdo principal
Ranking Invest

ETON - Eton Pharmaceuticals, Inc.

Segmento: HealthcareEton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Análise Ranking Invest

Valuation estimado
$ 48.68 Mi
Valor de Mercado
$ 1.63 Bi
Sobrepreço (AV)+3245.7%
IVR
0.03A companhia vale 0,03 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.00O valuation alternativo equivale a 0% do valor de mercado da companhia.
MLL
0.00O lucro líquido dos controladores em 16 trimestres equivale a 0% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 46.59 Mi

Dívida Líquida

$ 1.06 Mi

L4T

$ 12.69 Mi

MM4T

8.90%

Indicadores Básicos

ROE

27.24%

Índices de Previsibilidade

Receita Líquida

F0.38

Lucro

F2.70

Margem

F2.25

Índices de Tendência

Receita Líquida

B10.49

Lucro

D1.39

Margem

B5.83

Índices de Endividamento

DIV/PAT

0.02

DIV/L4T

0.08

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.